Skip to main content
Erschienen in: Indian Journal of Pediatrics 10/2010

01.10.2010 | Symposium on Pediatric Rheumatology-II

Fevers and the Rheumatologist

verfasst von: Prudence Joan Manners, Robin Guttinger

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Fevers in children are mainly due to infection, malignancy or inflammatory conditions. Rheumatologists have an important role in the care of inflammatory conditions, many of which are associated with fevers. Seven conditions, the hereditary recurrent fever syndromes, have been defined with the presenting symptom of recurring fever, and for which mutation of a single gene has been defined: Chronic infantile neurological articular syndrome (CINCA), Familial cold autoinflammatory syndrome (FACS), Familial Mediterranean fever (FMF), hyperimmunoglobulinemia D (HIDS), Muckle-Wells syndrome (MWS), Pyogenic sterile arthritis and Pyoderma gangrenosum (PAPA) and Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) . These conditions will be discussed in detail in regard to how they fit into the wider picture of pediatric rheumatological conditions, how the diagnoses may be established and the current recommended treatments for each condition.
Literatur
1.
Zurück zum Zitat Gattorno M, Caorsi R, Meini A, et al. Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics. 2009;124:e721–8.CrossRefPubMed Gattorno M, Caorsi R, Meini A, et al. Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics. 2009;124:e721–8.CrossRefPubMed
2.
Zurück zum Zitat Samuels J, Ozen S. Familial mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006;18:108–17.CrossRefPubMed Samuels J, Ozen S. Familial mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006;18:108–17.CrossRefPubMed
3.
Zurück zum Zitat Inal A, Yilmaz M, Kendirli S, et al. The clinical and genetical features of 124 children with familial mediterranean fever: experience of a single tertiary center. Rheumatol Int. 2009;29:1279–85.CrossRefPubMed Inal A, Yilmaz M, Kendirli S, et al. The clinical and genetical features of 124 children with familial mediterranean fever: experience of a single tertiary center. Rheumatol Int. 2009;29:1279–85.CrossRefPubMed
4.
Zurück zum Zitat Marek-Yagel D, Berhum Y, Padeh S, et al. Clinical disease among patients heterozygous for familial mediterranean fever. Arth Rheum. 2009;60:1862–6.CrossRef Marek-Yagel D, Berhum Y, Padeh S, et al. Clinical disease among patients heterozygous for familial mediterranean fever. Arth Rheum. 2009;60:1862–6.CrossRef
6.
Zurück zum Zitat Saketkoo L, Gedalia A. A child with recurrrent episodes of fever and joint pain. Clin Pediatr. 2009;48:215–9.CrossRef Saketkoo L, Gedalia A. A child with recurrrent episodes of fever and joint pain. Clin Pediatr. 2009;48:215–9.CrossRef
7.
Zurück zum Zitat Yalcinkaya F, Ozen S, Ozcakar Z, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48:395–8.CrossRefPubMed Yalcinkaya F, Ozen S, Ozcakar Z, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48:395–8.CrossRefPubMed
8.
Zurück zum Zitat Roldan R, Ruiz A, Miranda M, et al. Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine. 2008;75:504–5.CrossRefPubMed Roldan R, Ruiz A, Miranda M, et al. Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine. 2008;75:504–5.CrossRefPubMed
9.
Zurück zum Zitat Calligaris L, Marchetti F, Tommasini A, Ventura A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr. 2008;167:695–6.CrossRefPubMed Calligaris L, Marchetti F, Tommasini A, Ventura A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr. 2008;167:695–6.CrossRefPubMed
10.
Zurück zum Zitat Prietsch V, Mayatapek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics. 2003;111:258–61.CrossRefPubMed Prietsch V, Mayatapek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics. 2003;111:258–61.CrossRefPubMed
11.
Zurück zum Zitat Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43:410–5.CrossRefPubMed Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43:410–5.CrossRefPubMed
12.
Zurück zum Zitat Gattorno M, Federici S, Pelagatti M, Carosi R, et al. Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol. 2008;28 Suppl 1:S73–83.CrossRefPubMed Gattorno M, Federici S, Pelagatti M, Carosi R, et al. Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol. 2008;28 Suppl 1:S73–83.CrossRefPubMed
13.
Zurück zum Zitat Farasat S, Aksentijevich I, Toro J. Autoinflammatory diseases. Arch Dermatol. 2008;144:392–402.CrossRefPubMed Farasat S, Aksentijevich I, Toro J. Autoinflammatory diseases. Arch Dermatol. 2008;144:392–402.CrossRefPubMed
14.
Zurück zum Zitat Steichen O, van der Hilst J, Cuisset L, et al. A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol. 2009;36:1677–81.CrossRefPubMed Steichen O, van der Hilst J, Cuisset L, et al. A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol. 2009;36:1677–81.CrossRefPubMed
15.
Zurück zum Zitat van der Hilst J, Bodar E, Barron K, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301–10.CrossRefPubMed van der Hilst J, Bodar E, Barron K, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301–10.CrossRefPubMed
16.
Zurück zum Zitat Simon A, Drewe E, van der Meer JW, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004;75:476–83.CrossRefPubMed Simon A, Drewe E, van der Meer JW, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004;75:476–83.CrossRefPubMed
17.
Zurück zum Zitat van der Hilst J, Bodar E, Barron K, et al. Long-term follow-up, clincal featrues, and qualtiy of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301–10.CrossRefPubMed van der Hilst J, Bodar E, Barron K, et al. Long-term follow-up, clincal featrues, and qualtiy of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301–10.CrossRefPubMed
18.
Zurück zum Zitat Takeda K, Aksentijevich I, Mahadevan V, et al. Favourable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arth Rheum. 2003;48:2645–51.CrossRef Takeda K, Aksentijevich I, Mahadevan V, et al. Favourable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arth Rheum. 2003;48:2645–51.CrossRef
19.
Zurück zum Zitat Marchetti F, Barbi E, Tommasini A, et al. Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol. 2004;22:791–2.PubMed Marchetti F, Barbi E, Tommasini A, et al. Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol. 2004;22:791–2.PubMed
20.
Zurück zum Zitat Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner J, et al. Use of Canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416–25.CrossRefPubMed Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner J, et al. Use of Canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360:2416–25.CrossRefPubMed
21.
Zurück zum Zitat Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am. 2004;24:246–9.CrossRef Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am. 2004;24:246–9.CrossRef
22.
Zurück zum Zitat Hawkins PN, Lachmann HJ, Aganna E, McDermot MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arth Rheum. 2004;50:607–12.CrossRef Hawkins PN, Lachmann HJ, Aganna E, McDermot MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arth Rheum. 2004;50:607–12.CrossRef
23.
Zurück zum Zitat Hoffman HM, Rosengren S, Boyle DL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779–85.CrossRefPubMed Hoffman HM, Rosengren S, Boyle DL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779–85.CrossRefPubMed
24.
Zurück zum Zitat Ben-Chetrit E, Touitou I. Familial mediterranean fever in the world. Arthritis Care Res. 2009;61:1447–53.CrossRef Ben-Chetrit E, Touitou I. Familial mediterranean fever in the world. Arthritis Care Res. 2009;61:1447–53.CrossRef
25.
Zurück zum Zitat Aganna E, Hammond L, Hawkins PN, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632–44.CrossRefPubMed Aganna E, Hammond L, Hawkins PN, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632–44.CrossRefPubMed
26.
Zurück zum Zitat Houten S, van Woerden C, Wiburg F, et al. Carrier frequency of the V3771(1129G > A) MVK mutation. Eur J Hum Genet. 2003;11:196–200.CrossRefPubMed Houten S, van Woerden C, Wiburg F, et al. Carrier frequency of the V3771(1129G > A) MVK mutation. Eur J Hum Genet. 2003;11:196–200.CrossRefPubMed
27.
Zurück zum Zitat Marshall S, Edwards L, Butler J, et al. Syndrome of periodic fever, pharyngitis and aphthous stomatitis. J Pediatr. 1987;110:43–6.CrossRefPubMed Marshall S, Edwards L, Butler J, et al. Syndrome of periodic fever, pharyngitis and aphthous stomatitis. J Pediatr. 1987;110:43–6.CrossRefPubMed
28.
Zurück zum Zitat Garavello W, Romagnoli M, Gaini RM. Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomised study. J Pediatr. 2009;155:250–3.CrossRefPubMed Garavello W, Romagnoli M, Gaini RM. Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomised study. J Pediatr. 2009;155:250–3.CrossRefPubMed
29.
Zurück zum Zitat Leong S, Karkos P, Apostolidou M. Is there a role for the otolaryngologist in PFAPA syndrome? Int Pediatr Otorhinolaryngol. 2006;70:1841–5.CrossRef Leong S, Karkos P, Apostolidou M. Is there a role for the otolaryngologist in PFAPA syndrome? Int Pediatr Otorhinolaryngol. 2006;70:1841–5.CrossRef
30.
Zurück zum Zitat Tasher D, Stein M, Dalal I, et al. Cochicine prohpylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adentis episodes. Acta Paediatrica, Int J. Pediatr. 2008;97:1090–2.CrossRef Tasher D, Stein M, Dalal I, et al. Cochicine prohpylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adentis episodes. Acta Paediatrica, Int J. Pediatr. 2008;97:1090–2.CrossRef
Metadaten
Titel
Fevers and the Rheumatologist
verfasst von
Prudence Joan Manners
Robin Guttinger
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2010
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-010-0206-y

Weitere Artikel der Ausgabe 10/2010

Indian Journal of Pediatrics 10/2010 Zur Ausgabe

Symposium on AIIMS Protocols in Neonatology-I

Management of Polycythemia in Neonates

Scientific Letters to the Editor

Encephalitis Following Wasp Sting

Symposium on AIIMS Protocols in Neonatology-I

Hypoglycemia in the Newborn

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.